TRHC Clinical Pharmacists and PACE Medical Directors Gather to Learn
MOORESTOWN, N.J., Sept. 20, 2018 (GLOBE NEWSWIRE) -- CareKinesis, a subsidiary of Tabula Rasa HealthCare (NASDAQ:TRHC), is hosting its 12th Clinical Advisory Panel (CAP) Meeting, bringing together the Program of All-Inclusive Care for the Elderly (PACE) medical directors from across the country.
According to TRHC Co-founder and President Orsula V. Knowlton, PharmD, MBA, the CAP Meeting provides “a productive forum for our clinical pharmacists to interact with the medical directors, ensuring we are collaborating to the maximum benefit of our PACE participants.”
The CAP Meeting is a recognized and anticipated training and education event for PACE medical directors, and a forum where clinical thought-leaders discuss the value TRHC brings to patient care. CME, ACPE and CNE continuing education credits are available to participants.
Selected topics to be presented and discussed during the two-day conference include:
- Anticholinergic Burden, Sedative Burden, and Pharmacogenomics (PGx)
- Enhanced Medication Therapy Management
- Competitive Inhibition and LQTS: Managing Accumulative, Multi-Drug Interactions
- Risk Stratification Models, including TRHC’s unique and proprietary Medication Risk Score™
- Fundamentals of Treating Pain in Geriatrics
Additionally, medical directors new to the PACE program will receive an orientation to pharmacodynamics (how medications react in the body) and pharmacokinetics (how the body reacts to medications) from TRHC Chief Medical Officer Richard Schamp, MD, and TRHC Chief Executive Officer, Calvin H. Knowlton, PhD.
Of special interest to medical directors is an in-depth examination of various risk stratification models (including results achieved using TRHC’s Medication Risk Score™ and medication risk stratification approach) and the fundamentals of treating pain in geriatrics. Kevin Bain, PharmD, MPH, TRHC Senior Vice President for Research and Development, and David Wensel, DO, Medical Director at Midland Care, will define the concepts of risk stratification and distinguish how risk stratification models are used as predictive tools. They will discuss the use of alternative pain management strategies. “Success stories” from PACE will be highlighted.
Other TRHC presenters include George W. “Mike” Brett, MD, Senior Vice President for Consulting Services and Chief Medical Officer, Capstone Performance Systems, a TRHC subsidiary; Robert Alesiani, PharmD, Chief Pharmacotherapy Officer; Alan Stein, MD, PhD, Senior Vice President for Healthcare Analytics; and Lauren Steffen, PharmD, Director of Education and Training.
The meeting is being held September 20-21 in Orlando, Florida.
About Tabula Rasa HealthCare
TRHC (NASDAQ:TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. TRHC provides solutions for a range of payers, providers and other healthcare organizations. For more information, visit TRHC.com. Follow us on Twitter @TabulaRasaHC for up-to-date information.
Forward-Looking Statements
This press release includes forward-looking statements that we believe to be reasonable as of today’s date, including statements regarding Medication Risk Mitigation technology. Such statements are identified by use of the words “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” “predicts,” “projects,” “should,” and similar expressions. These forward-looking statements are based on management’s expectations and assumptions as of the date of this press release. Actual results might differ materially from those explicit or implicit in the forward-looking statements. Important factors that could cause actual results to differ materially include: the need to innovate and provide useful products and services; risks related to changing healthcare and other applicable regulations; increasing consolidation in the healthcare industry; managing our growth effectively; our ability to adequately protect our intellectual property; and the other risk factors set forth from time to time in our filings with the SEC, including those factors discussed under the caption “Risk Factors” in our most recent annual report on Form 10-K, filed with the SEC on March 14, 2018, and in subsequent reports filed with or furnished to the SEC, copies of which are available free of charge within the Investor Relations section of the TRHC website http://ir.trhc.com or upon request from our Investor Relations Department. Any forward-looking statement speaks only as of the date on which it was made. TRHC assumes no obligation and does not intend to update these forward-looking statements, except as required by law, to reflect events or circumstances occurring after today’s date.
Media Contact
Dianne Semingson
dsemingson@TRHC.com
T: 215-870-0829
Investors
Bob East or Asher Dewhurst
Westwicke Partners
443-213-0500
tabularasa@westwicke.com